Logo

American Heart Association

  21
  0


Final ID: MP10

Missed Opportunities for Stroke Prevention in Hypertensive Patients: A Retrospective Case-Control Study

Abstract Body (Do not enter title and authors here): Background: Hypertension, observed in 64% of patients presenting with stroke, is a well-established risk factor for stroke-related mortality, with elevated systolic blood pressure (BP) playing a particularly significant role.
Research Questions: To what extent are missed opportunities in outpatient hypertension management associated with increased risk of ischemic stroke?
Methods: We conducted a retrospective case-control study within a longitudinal cohort of hypertensive patients using electronic health records from Sentara Health. First-ever ischemic stroke cases were matched 1:4 to hypertensive controls without stroke by age, sex, race, ethnicity, and onset date of hypertension (T0). Follow-up spanned from T0 to first stroke admission (T1) or a matched outpatient visit (pseudo-T1) for controls. We evaluated the following metrics in follow-up periods: (1) total number of outpatient visits with BP recorded; (2) the total number of antihypertensive prescriptions received; and (3) the percentage of outpatient visits with antihypertensive drug adjustment (change in antihypertensive drug class). Group differences were tested using t-tests and chi-square tests. Adjusted odds ratios (aORs) for stroke were estimated using conditional multivariable logistic regression controlling for demographics and comorbidities.
Results: The study included 10,825 stroke cases and 37,195 matched controls. Among the total 48,020 individuals, 26,201 (54.6%) were women. The mean (SD) age was 64.3 (12.8) years, and the mean (SD) follow-up duration (T1–T0) was 5.4 (3.6) years. Compared with controls, stroke cases had fewer total outpatient visits (mean: 16.2 vs. 18.1; p < 0.001), fewer total antihypertensive prescriptions received (3.6 vs. 4.4; p < 0.001), and lower rate of medication adjustments (16.8% vs. 19.4%; p < 0.001). The adjusted conditional logistic regression showed that more outpatient visits (aOR = 0.991; 95% CI: 0.990–0.992), antihypertensive prescriptions (aOR = 0.995; 95% CI: 0.985–0.999), and higher medication adjustment percentage (aOR = 0.993; 95% CI: 0.991–0.994) were all significantly associated with reduced odds of stroke.
Conclusion: Missed opportunities in hypertension management including lack of follow-up, underuse and infrequent adjustment of antihypertensive therapy, which are associated with higher stroke risk. Interventions targeting more aggressive medication prescribing and adjustment practices may reduce the burden of stroke among hypertensive patients.
  • Yang, Huanhuan  ( Yale New Haven Hospital , New Haven , Connecticut , United States )
  • Lu, Yuan  ( Yale New Haven Hospital , New Haven , Connecticut , United States )
  • Liu, Yuntian  ( Yale School of Medicine , New Haven , Connecticut , United States )
  • Kim, Chungsoo  ( Yale New Haven Hospital , New Haven , Connecticut , United States )
  • Huang, Chenxi  ( Yale New Haven Hospital , New Haven , Connecticut , United States )
  • Sawano, Mitsuaki  ( Yale New Haven Hospital , New Haven , Connecticut , United States )
  • Young, Patrick  ( Yale School of Medicine , New Haven , Connecticut , United States )
  • Anderson, Mark  ( Sentara Health Research Center , Norfolk , Virginia , United States )
  • Krumholz, Harlan  ( Yale New Haven Hospital , New Haven , Connecticut , United States )
  • Brush, John  ( Sentara Health Research Center , Norfolk , Virginia , United States )
  • Author Disclosures:
    Huanhuan Yang: DO NOT have relevant financial relationships | Yuan Lu: DO NOT have relevant financial relationships | Yuntian Liu: DO NOT have relevant financial relationships | Chungsoo Kim: DO NOT have relevant financial relationships | Chenxi Huang: DO NOT have relevant financial relationships | Mitsuaki Sawano: DO have relevant financial relationships ; Research Funding (PI or named investigator):Polybio:Active (exists now) ; Speaker:Boehringer Ingelheim:Past (completed) ; Research Funding (PI or named investigator):Pfizer:Past (completed) ; Research Funding (PI or named investigator):Novartis:Active (exists now) | Patrick Young: No Answer | Mark Anderson: DO NOT have relevant financial relationships | Harlan Krumholz: No Answer | John Brush: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Intersecting Pathways: Cardiac Health, Therapies, and Stroke Prevention Gaps

Saturday, 11/08/2025 , 12:15PM - 01:30PM

Moderated Digital Poster Session

More abstracts on this topic:
A ChatGLM-based stroke diagnosis and prediction tool

Song Xiaowei, Wang Jiayi, Ma Weizhi, Wu Jian, Wang Yueming, Gao Ceshu, Wei Chenming, Pi Jingtao

A cerebrovascular longitudinal atlas: different rates of morphological change in aneurysm patients associated with hypertension and diabetes

Chien Aichi, Salamon Noriko, Vinuela Fernando, Szeder Viktor, Colby Geoffrey, Jahan Reza, Boyle Noel, Villablanca Juan, Duckwiler Gary

More abstracts from these authors:
Resistant Hypertension and BP Trajectories: EHR Insights into PA and OSA Screening Practices

Wu Qifan, Lu Yuan, Sawano Mitsuaki, Kim Chungsoo, Krumholz Harlan

Real-World Impact of Semaglutide on Cardiometabolic Risk Factors in Patients without Diabetes: A Multi-Center Analysis of Electronic Health Records

Kim Chungsoo, Liu Yuntian, Jastreboff Ania, Khera Rohan, Krumholz Harlan, Brush John, Lu Yuan

You have to be authorized to contact abstract author. Please, Login
Not Available